CLINICAL_TRIALS
trial_result
· 2026-04-01
Clinical Trial Update: A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
Summary
The clinical trial update reports termination of a Phase 1/2 study of GDX012 in adults with relapsed or refractory acute myeloid leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Leukemia | Phase 1, Phase 2 | Status: TERMINATED